- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Swissray nears sale of x-ray assets
The first company to introduce a digital radiography system in the U.S. may soon be sold. Swissray International announced Sept. 24 the signing of a nonbinding letter of intent with a U.S.-based private equity firm to acquire all the outstanding shares
The first company to introduce a digital radiography system in the U.S. may soon be sold. Swissray International announced Sept. 24 the signing of a nonbinding letter of intent with a U.S.-based private equity firm to acquire all the outstanding shares of Swissray's capital stock. Swissray has installed its CCD-based ddR (direct digital radiography) systems in the U.S., Europe, the Middle East, and Asia. The company began shopping for a buyer in February at the behest of its major shareholder Hillcrest Avenue, which owns more than 52 million of the company's 91 million common shares. The letter provides for a limited exclusivity period in which to conduct due diligence, to agree on the form and terms of the transaction, and to enter into a definitive contract. Neither Swissray nor its major stockholders may pursue other potential buyers during this time. If the letter of intent is terminated, sale to another buyer within six months will require Swissray to pay a penalty.
AI Mammography Platform Shows Promising Results for Detecting Subclinical Breast Cancer
October 3rd 2024Mean artificial intelligence (AI) scoring for breasts developing cancer was double that of contralateral breasts at initial biennial screening and was 16 times higher at the third biennial screening, according to a study involving over 116,000 women with no prior history of breast cancer.
CT Study Links Pleural Effusion and Higher 30-Day Mortality Rates in Patients with COVID-19
October 1st 2024In a multicenter study of over 1,100 patients with COVID-19, pleural effusion was detected on CT scans in nearly a third of patients, who also had significantly higher ICU admission and 30-day mortality rates.
